Attinà T - Search Results

1

Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.

Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS. Mangiafico RA, et al. Among authors: attina t. Angiology. 2000 Jun;51(6):441-9. doi: 10.1177/000331970005100601. Angiology. 2000. PMID: 10870853 Clinical Trial.

2

Exaggerated endothelin release in response to acute mental stress in patients with intermittent claudication.

Mangiafico RA, Malatino LS, Attinà T, Messina R, Fiore CE. Mangiafico RA, et al. Among authors: attina t. Angiology. 2002 Jul-Aug;53(4):383-90. doi: 10.1177/000331970205300403. Angiology. 2002. PMID: 12143942

3

Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.

Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F. Mangiafico RA, et al. Among authors: attina t. Int J Clin Pharmacol Ther. 1999 Jul;37(7):347-51. Int J Clin Pharmacol Ther. 1999. PMID: 10442509 Clinical Trial.

4

Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb.

Mangiafico RA, Malatino LS, Spada RS, Santonocito M, Messina R, Dell'Arte S, Attinà T. Mangiafico RA, et al. Among authors: attina t. Int Angiol. 2000 Mar;19(1):14-7. Int Angiol. 2000. PMID: 10853680

5

[Hypertensive encephalopathy associated with malignant and resistant hypertension].

Mangiafico RA, Spada RS, Messina R, Attinà T, Santonocito M, Dell'Arte S. Mangiafico RA, et al. Among authors: attina t. Minerva Cardioangiol. 1998 Sep;46(9):347-8. Minerva Cardioangiol. 1998. PMID: 10021875 Italian. No abstract available.

6

[Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2].

Mangiafico RA, Malatino LS, Attinà T, Dell'Arte S, Messina R. Mangiafico RA, et al. Among authors: attina t. Minerva Cardioangiol. 1999 Dec;47(12):652-3. Minerva Cardioangiol. 1999. PMID: 10670246 Clinical Trial. Italian. No abstract available.

7

Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed.

Attinà TM, Oliver JJ, Malatino LS, Webb DJ. Attinà TM, et al. Br J Clin Pharmacol. 2008 Aug;66(2):300-3. doi: 10.1111/j.1365-2125.2008.03194.x. Epub 2008 Apr 10. Br J Clin Pharmacol. 2008. PMID: 18489612 Free PMC article. Clinical Trial.

8

Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.

Attinà TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ. Attinà TM, et al. J Hypertens. 2008 Mar;26(3):501-7. doi: 10.1097/HJH.0b013e3282f382ff. J Hypertens. 2008. PMID: 18300861 Clinical Trial.

9

Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men.

Attinà TM, Drummond ID, Malatino LS, Maxwell SR, Webb DJ. Attinà TM, et al. Am J Hypertens. 2013 Mar;26(3):342-50. doi: 10.1093/ajh/hps057. Epub 2013 Jan 7. Am J Hypertens. 2013. PMID: 23382484 Clinical Trial.

10

The effect of cerivastatin therapy on vascular responses to endothelin antagonists in humans.

Leslie SJ, Spratt JC, Grieg L, Attina T, Denvir MA, Webb DJ. Leslie SJ, et al. Among authors: attina t. J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S410-2. doi: 10.1097/01.fjc.0000166290.95195.8b. J Cardiovasc Pharmacol. 2004. PMID: 15838335 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page